1. Department of Cardiology and Laboratory of Heart Valve Disease, West China Hospital, Sichuan University, Chengdu 610041, China 2. Department of Cardiology, Zhongshan Hospital, Fudan University, Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai 200032, China 3. Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China 4. National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine (19MC1910300), Shanghai 200032, China
Atherosclerosis is a chronic artery disease that causes various types of cardiovascular dysfunction. Vascular smooth muscle cells (VSMCs), the main components of atherosclerotic plaque, switch from contractile to synthetic phenotypes during atherogenesis. Ubiquitylation is crucial in regulating VSMC phenotypes in atherosclerosis, and it can be reversely regulated by deubiquitinases. However, the specific effects of deubiquitinases on atherosclerosis have not been thoroughly elucidated. In this study, RNAi screening in human aortic smooth muscle cells was performed to explore the effects of OTU family deubiquitinases, which revealed that silencing OTUB1 inhibited PDGF-BB-stimulated VSMC phenotype switch. Further in vivo studies using Apoe−/− mice revealed that knockdown of OTUB1 in VSMCs alleviated atherosclerosis plaque burden in the advanced stage and led to a stable plaque phenotype. Moreover, VSMC proliferation and migration upon PDGF-BB stimulation could be inhibited by silencing OTUB1 in vitro. Unbiased RNA-sequencing data indicated that knocking down OTUB1 influenced VSMC differentiation, adhesion, and proliferation. Mass spectrometry of ubiquitinated protein confirmed that proteins related to cell growth and migration were differentially ubiquitylated. Mechanistically, we found that OTUB1 recognized the K707 residue ubiquitylation of PDGFRβ with its catalytic triad, thereby reducing the K48-linked ubiquitylation of PDGFRβ. Inhibiting OTUB1 in VSMCs could promote PDGFRβ degradation via the ubiquitin–proteasome pathway, so it was beneficial in preventing VSMCs’ phenotype switch. These findings revealed that knocking down OTUB1 ameliorated VSMCs’ phenotype switch and atherosclerosis progression, indicating that OTUB1 could be a valuable translational therapeutic target in the future.
P Golforoush, DM Yellon, SM Davidson. Mouse models of atherosclerosis and their suitability for the study of myocardial infarction. Basic Res Cardiol 2020; 115(6): 73 https://doi.org/10.1007/s00395-020-00829-5
7
P Swiatlowska, B Sit, Z Feng, E Marhuenda, I Xanthis, S Zingaro, M Ward, X Zhou, Q Xiao, C Shanahan, GE Jones, CH Yu, T Iskratsch. Pressure and stiffness sensing together regulate vascular smooth muscle cell phenotype switching. Sci Adv 2022; 8(15): eabm3471 https://doi.org/10.1126/sciadv.abm3471
8
C Borgo, C D’Amore, S Sarno, M Salvi, M Ruzzene. Protein kinase CK2: a potential therapeutic target for diverse human diseases. Signal Transduct Target Ther 2021; 6(1): 183 https://doi.org/10.1038/s41392-021-00567-7
9
J Herrmann, SM Soares, LO Lerman, A Lerman. Potential role of the ubiquitin-proteasome system in atherosclerosis: aspects of a protein quality disease. J Am Coll Cardiol 2008; 51(21): 2003–2010 https://doi.org/10.1016/j.jacc.2008.02.047
10
M Demasi, FR Laurindo. Physiological and pathological role of the ubiquitin-proteasome system in the vascular smooth muscle cell. Cardiovasc Res 2012; 95(2): 183–193 https://doi.org/10.1093/cvr/cvs128
11
MOJ Grootaert, A Finigan, NL Figg, AK Uryga, MR Bennett. SIRT6 protects smooth muscle cells from senescence and reduces atherosclerosis. Circ Res 2021; 128(4): 474–491 https://doi.org/10.1161/CIRCRESAHA.120.318353
12
M Ye, X Guo, H Wang, Y Wang, X Qian, H Deng, W Wang, S Yang, Q Ni, J Chen, L Lv, Y Zhao, G Xue, Y Li, L Zhang. Mutual regulation between β-TRCP mediated REST protein degradation and Kv1.3 expression controls vascular smooth muscle cell phenotype switch. Atherosclerosis 2020; 313: 102–110 https://doi.org/10.1016/j.atherosclerosis.2020.08.018
13
SM Lange, LA Armstrong, Y Kulathu. Deubiquitinases: from mechanisms to their inhibition by small molecules. Mol Cell 2022; 82(1): 15–29 https://doi.org/10.1016/j.molcel.2021.10.027
14
TE Mevissen, MK Hospenthal, PP Geurink, PR Elliott, M Akutsu, N Arnaudo, R Ekkebus, Y Kulathu, T Wauer, F El Oualid, SM Freund, H Ovaa, D Komander. OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell 2013; 154(1): 169–184 https://doi.org/10.1016/j.cell.2013.05.046
15
MJ Clague, S Urbé, D Komander. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat Rev Mol Cell Biol 2019; 20(6): 338–352 https://doi.org/10.1038/s41580-019-0099-1
16
Y Liao, M Yang, K Wang, Y Wang, B Zhong, N Jiang. Deubiquitinating enzyme OTUB1 in immunity and cancer: good player or bad actor?. Cancer Lett 2022; 526: 248–258 https://doi.org/10.1016/j.canlet.2021.12.002
17
F Mulas, X Wang, S Song, G Nishanth, W Yi, A Brunn, PK Larsen, B Isermann, U Kalinke, A Barragan, M Naumann, M Deckert, D Schlüter. The deubiquitinase OTUB1 augments NF-κB-dependent immune responses in dendritic cells in infection and inflammation by stabilizing UBC13. Cell Mol Immunol 2021; 18(6): 1512–1527 https://doi.org/10.1038/s41423-020-0362-6
18
J Koschel, G Nishanth, S Just, K Harit, A Kröger, M Deckert, M Naumann, D Schlüter. OTUB1 prevents lethal hepatocyte necroptosis through stabilization of c-IAP1 during murine liver inflammation. Cell Death Differ 2021; 28(7): 2257–2275 https://doi.org/10.1038/s41418-021-00752-9
19
T Bonacci, A Suzuki, GD Grant, N Stanley, JG Cook, NG Brown, MJ Emanuele. Cezanne/OTUD7B is a cell cycle-regulated deubiquitinase that antagonizes the degradation of APC/C substrates. EMBO J 2018; 37(16): e98701 https://doi.org/10.15252/embj.201798701
20
Q Luo, X Wu, P Zhao, Y Nan, W Chang, X Zhu, D Su, Z Liu. OTUD1 Activates caspase-independent and caspase-dependent apoptosis by promoting AIF nuclear translocation and MCL1 degradation. Adv Sci (Weinh) 2021; 8(8): 2002874 https://doi.org/10.1002/advs.202002874
21
GS Yang, B Zheng, Y Qin, J Zhou, Z Yang, XH Zhang, HY Zhao, HJ Yang, JK Wen. Salvia miltiorrhiza-derived miRNAs suppress vascular remodeling through regulating OTUD7B/KLF4/NMHC IIA axis. Theranostics 2020; 10(17): 7787–7811 https://doi.org/10.7150/thno.46911
22
U Karunarathna, M Kongsema, S Zona, C Gong, E Cabrera, AR Gomes, EP Man, P Khongkow, JW Tsang, US Khoo, RH Medema, R Freire, EW Lam. OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance. Oncogene 2016; 35(11): 1433–1444 https://doi.org/10.1038/onc.2015.208
23
D Zhu, R Xu, X Huang, Z Tang, Y Tian, J Zhang, X Zheng. Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1. Cell Death Differ 2021; 28(6): 1773–1789 https://doi.org/10.1038/s41418-020-00700-z
24
AS Jahan, E Biquand, R Muñoz-Moreno, Quang A Le, CK Mok, HH Wong, QW Teo, SA Valkenburg, AWH Chin, Poon LL Man, Velthuis A Te, A García-Sastre, C Demeret, S Sanyal. OTUB1 is a key regulator of RIG-I-dependent immune signaling and is targeted for proteasomal degradation by influenza A NS1. Cell Rep 2020; 30(5): 1570–1584.e6 https://doi.org/10.1016/j.celrep.2020.01.015
25
S Liu, X Jiang, X Cui, J Wang, S Liu, H Li, J Yang, C Zhang, W Zhang. Smooth muscle-specific HuR knockout induces defective autophagy and atherosclerosis. Cell Death Dis 2021; 12(4): 385 https://doi.org/10.1038/s41419-021-03671-2
26
JR Wiśniewski, A Zougman, N Nagaraj, M Mann. Universal sample preparation method for proteome analysis. Nat Methods 2009; 6(5): 359–362 https://doi.org/10.1038/nmeth.1322
27
D Shin, A Bhattacharya, YL Cheng, MC Alonso, AR Mehdipour, GJ van der Heden van Noort, H Ovaa, G Hummer, I Dikic. Bacterial OTU deubiquitinases regulate substrate ubiquitination upon Legionella infection. Elife 2020; 9: e58277 https://doi.org/10.7554/eLife.58277
28
AF Schubert, JV Nguyen, TG Franklin, PP Geurink, CG Roberts, DJ Sanderson, LN Miller, H Ovaa, K Hofmann, JN Pruneda, D Komander. Identification and characterization of diverse OTU deubiquitinases in bacteria. EMBO J 2020; 39(15): e105127 https://doi.org/10.15252/embj.2020105127
29
E Biros, G Gäbel, CS Moran, C Schreurs, JH Lindeman, PJ Walker, M Nataatmadja, M West, LM Holdt, I Hinterseher, C Pilarsky, J Golledge. Differential gene expression in human abdominal aortic aneurysm and aortic occlusive disease. Oncotarget 2015; 6(15): 12984–12996 https://doi.org/10.18632/oncotarget.3848
30
L Herhaus, M Al-Salihi, T Macartney, S Weidlich, GP Sapkota. OTUB1 enhances TGFβ signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3. Nat Commun 2013; 4(1): 2519 https://doi.org/10.1038/ncomms3519
31
Y Li, JY Yang, X Xie, Z Jie, L Zhang, J Shi, D Lin, M Gu, X Zhou, HS Li, SS Watowich, A Jain, S Yun Jung, J Qin, X Cheng, SC Sun. Preventing abnormal NF-κB activation and autoimmunity by Otub1-mediated p100 stabilization. Cell Res 2019; 29(6): 474–485 https://doi.org/10.1038/s41422-019-0174-3
32
Q Zhu, Y Fu, L Li, CH Liu, L Zhang. The functions and regulation of Otubains in protein homeostasis and diseases. Ageing Res Rev 2021; 67: 101303 https://doi.org/10.1016/j.arr.2021.101303
33
A Ruiz-Serrano, Rodríguez JM Monné, J Günter, SPM Sherman, AE Jucht, P Fluechter, YL Volkova, S Pfundstein, G Pellegrini, CA Wagner, C Schneider, RH Wenger, CC Scholz. OTUB1 regulates lung development, adult lung tissue homeostasis, and respiratory control. FASEB J 2021; 35(12): e22039 https://doi.org/10.1096/fj.202100346R
34
A Cheng, CE Grant, WS Noble, TL Bailey. MoMo: discovery of statistically significant post-translational modification motifs. Bioinformatics 2019; 35(16): 2774–2782 https://doi.org/10.1093/bioinformatics/bty1058
35
Y Baumer, S McCurdy, M Alcala, N Mehta, BH Lee, MH Ginsberg, WA Boisvert. CD98 regulates vascular smooth muscle cell proliferation in atherosclerosis. Atherosclerosis 2017; 256: 105–114 https://doi.org/10.1016/j.atherosclerosis.2016.11.017
36
EJ Goetzl, JB Schwartz, M Mustapic, IV Lobach, R Daneman, EL Abner, GA Jicha. Altered cargo proteins of human plasma endothelial cell-derived exosomes in atherosclerotic cerebrovascular disease. FASEB J 2017; 31(8): 3689–3694 https://doi.org/10.1096/fj.201700149
37
C He, SC Medley, T Hu, ME Hinsdale, F Lupu, R Virmani, LE Olson. PDGFRβ signalling regulates local inflammation and synergizes with hypercholesterolaemia to promote atherosclerosis. Nat Commun 2015; 6(1): 7770 https://doi.org/10.1038/ncomms8770
D Iglesias-Gato, YC Chuan, N Jiang, C Svensson, J Bao, I Paul, L Egevad, BM Kessler, P Wikström, Y Niu, A Flores-Morales. OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo. Mol Cancer 2015; 14(1): 8 https://doi.org/10.1186/s12943-014-0280-2
40
X Han, C Ren, C Lu, P Qiao, T Yang, Z Yu. Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis. Cell Death Differ 2022; 29(9): 1864–1873 https://doi.org/10.1038/s41418-022-00971-8
41
T Goncharov, K Niessen, MC de Almagro, A Izrael-Tomasevic, AV Fedorova, E Varfolomeev, D Arnott, K Deshayes, DS Kirkpatrick, D Vucic. OTUB1 modulates c-IAP1 stability to regulate signalling pathways. EMBO J 2013; 32(8): 1103–1114 https://doi.org/10.1038/emboj.2013.62
42
A Martínez-Férriz, A Ferrando, A Fathinajafabadi, R Farràs. Ubiquitin-mediated mechanisms of translational control. Semin Cell Dev Biol 2022; 132: 146–154 https://doi.org/10.1016/j.semcdb.2021.12.009
43
Y Takayama, P May, RG Anderson, J Herz. Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor β (PDGFR β). J Biol Chem 2005; 280(18): 18504–18510 https://doi.org/10.1074/jbc.M410265200
44
X Wang, Y Li, M He, X Kong, P Jiang, X Liu, L Diao, X Zhang, H Li, X Ling, S Xia, Z Liu, Y Liu, CP Cui, Y Wang, L Tang, L Zhang, F He, D Li. UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase/deubiquitinase-substrate interactions in eukaryotic species. Nucleic Acids Res 2022; 50(D1): D719–D728 https://doi.org/10.1093/nar/gkab962
45
Z Li, S Chen, JH Jhong, Y Pang, KY Huang, S Li, TY Lee. UbiNet 2.0: a verified, classified, annotated and updated database of E3 ubiquitin ligase-substrate interactions. Database (Oxford) 2021; 2021: baab010 https://doi.org/10.1093/database/baab010
46
H Xu, J Zhou, S Lin, W Deng, Y Zhang, Y Xue. PLMD: an updated data resource of protein lysine modifications. J Genet Genomics 2017; 44(5): 243–250 https://doi.org/10.1016/j.jgg.2017.03.007
47
R Wiener, X Zhang, T Wang, C Wolberger. The mechanism of OTUB1-mediated inhibition of ubiquitination. Nature 2012; 483(7391): 618–622 https://doi.org/10.1038/nature10911
48
Y Zhang, Y Wang, L Zhang, L Xia, M Zheng, Z Zeng, Y Liu, T Yarovinsky, AC Ostriker, X Fan, K Weng, M Su, P Huang, KA Martin, J Hwa, WH Tang. Reduced platelet miR-223 induction in Kawasaki disease leads to severe coronary artery pathology through a miR-223/PDGFRβ vascular smooth muscle cell axis. Circ Res 2020; 127(7): 855–873 https://doi.org/10.1161/CIRCRESAHA.120.316951
49
AL Reddi, G Ying, L Duan, G Chen, M Dimri, P Douillard, BJ Druker, M Naramura, V Band, H Band. Binding of Cbl to a phospholipase Cgamma1-docking site on platelet-derived growth factor receptor beta provides a dual mechanism of negative regulation. J Biol Chem 2007; 282(40): 29336–29347 https://doi.org/10.1074/jbc.M701797200
50
T Hamid, Y Xu, MA Ismahil, G Rokosh, M Jinno, G Zhou, Q Wang, SD Prabhu. Cardiac mesenchymal stem cells promote fibrosis and remodeling in heart failure: role of PDGF signaling. JACC Basic Transl Sci 2022; 7(5): 465–483 https://doi.org/10.1016/j.jacbts.2022.01.004
51
AC Doran, N Meller, CA McNamara. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008; 28(5): 812–819 https://doi.org/10.1161/ATVBAHA.107.159327
52
M Saldana, K VanderVorst, AL Berg, H Lee, KL Carraway. Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer. Endocr Relat Cancer 2019; 26(1): R1–R14 https://doi.org/10.1530/ERC-18-0264
53
C Yap, A Mieremet, CJM de Vries, D Micha, V de Waard. Six shades of vascular smooth muscle cells illuminated by KLF4 (Krüppel-like factor 4). Arterioscler Thromb Vasc Biol 2021; 41(11): 2693–2707 https://doi.org/10.1161/ATVBAHA.121.316600
54
AL Durham, MY Speer, M Scatena, CM Giachelli, CM Shanahan. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness. Cardiovasc Res 2018; 114(4): 590–600 https://doi.org/10.1093/cvr/cvy010
55
XX Sun, KB Challagundla, MS Dai. Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1. EMBO J 2012; 31(3): 576–592 https://doi.org/10.1038/emboj.2011.434
56
PY Jean-Charles, JH Wu, L Zhang, S Kaur, I Nepliouev, JA Stiber, L Brian, R Qi, V Wertman, SK Shenoy, NJ Freedman. USP20 (ubiquitin-specific protease 20) inhibits TNF (tumor necrosis factor)-triggered smooth muscle cell inflammation and attenuates atherosclerosis. Arterioscler Thromb Vasc Biol 2018; 38(10): 2295–2305 https://doi.org/10.1161/ATVBAHA.118.311071
57
HP Moll, A Lee, DC Minussi, CG da Silva, E Csizmadia, M Bhasin, C Ferran. A20 regulates atherogenic interferon (IFN)-γ signaling in vascular cells by modulating basal IFNβ levels. J Biol Chem 2014; 289(45): 30912–30924 https://doi.org/10.1074/jbc.M114.591966
58
H Karvinen, J Rutanen, O Leppänen, R Lach, AL Levonen, U Eriksson, S Ylä-Herttuala. PDGF-C and -D and their receptors PDGFR-α and PDGFR-β in atherosclerotic human arteries. Eur J Clin Invest 2009; 39(4): 320–327 https://doi.org/10.1111/j.1365-2362.2009.02095.x
59
C Rorsman, M Tsioumpekou, CH Heldin, J Lennartsson. The ubiquitin ligases c-Cbl and Cbl-b negatively regulate platelet-derived growth factor (PDGF) BB-induced chemotaxis by affecting PDGF receptor β (PDGFRβ) internalization and signaling. J Biol Chem 2016; 291(22): 11608–11618 https://doi.org/10.1074/jbc.M115.705814
60
N Sarri, K Wang, M Tsioumpekou, C Castillejo-López, J Lennartsson, CH Heldin, N Papadopoulos. Deubiquitinating enzymes USP4 and USP17 finetune the trafficking of PDGFRβ and affect PDGF-BB-induced STAT3 signalling. Cell Mol Life Sci 2022; 79(2): 85 https://doi.org/10.1007/s00018-022-04128-1
61
AAC Newman, V Serbulea, RA Baylis, LS Shankman, X Bradley, GF Alencar, K Owsiany, RA Deaton, S Karnewar, S Shamsuzzaman, A Salamon, MS Reddy, L Guo, A Finn, R Virmani, OA Cherepanova, GK Owens. Multiple cell types contribute to the atherosclerotic lesion fibrous cap by PDGFRβ and bioenergetic mechanisms. Nat Metab 2021; 3(2): 166–181 https://doi.org/10.1038/s42255-020-00338-8
62
X Guo, L Nie, L Esmailzadeh, J Zhang, JR Bender, MM Sadeghi. Endothelial and smooth muscle-derived neuropilin-like protein regulates platelet-derived growth factor signaling in human vascular smooth muscle cells by modulating receptor ubiquitination. J Biol Chem 2009; 284(43): 29376–29382 https://doi.org/10.1074/jbc.M109.049684
63
BG Childs, DJ Baker, T Wijshake, CA Conover, J Campisi, JM van Deursen. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science 2016; 354(6311): 472–477 https://doi.org/10.1126/science.aaf6659
64
D Gomez, RA Baylis, BG Durgin, AAC Newman, GF Alencar, S Mahan, Hilaire C St, W Müller, A Waisman, SE Francis, E Pinteaux, GJ Randolph, H Gram, GK Owens. Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice. Nat Med 2018; 24(9): 1418–1429 https://doi.org/10.1038/s41591-018-0124-5
65
G Fredman, N Kamaly, S Spolitu, J Milton, D Ghorpade, R Chiasson, G Kuriakose, M Perretti, O Farokzhad, I Tabas. Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci Transl Med 2015; 7(275): 275ra20 https://doi.org/10.1126/scitranslmed.aaa1065
